Skip to Main Content

Paper Details

Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability.
bioRxiv
1
2023
CpG sites, High, High-neural glioblastoma cells, High-neural glioblastomas, brain, genes, glioblastoma, glioma, high, high-grade gliomas, high-neural glioblastoma, malignant neural, neural cells, neural glioblastoma, neural precursor cell-like, oligodendrocyte precursor, patients, plasma, stem, stem cell, stem cell-like malignant cells, tumor, tumor DNA
Author NameAffiliation
Peter VajkoczyCharite - Universitatsmedizin Berlin
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Benedikt WiestlerTechnical University Munich
Michael WellerClinical Neuroscience Center, University Hospital Zurich, University of Zurich
Tobias WeissClinical Neuroscience Center, University Hospital Zurich, University of Zurich
Michelle MonjeStanford University
Dana SilverbushBroad Institute of Harvard and MIT
Mario L Suv??Broad Institute of Harvard and MIT
Mario L Suv??Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School
Mario L Suv??Broad Institute of Harvard and MIT
Mario L Suv??Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School
Ulrich Sch??llerInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf
Ulrich Sch??llerResearch Institute Children's Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf
Ulrich Sch??llerResearch Institute Children's Cancer Center Hamburg
  • 1 - 15

Datasets

Release 1.2